Next Article in Journal
In Vitro Anticariogenic Effects of Drymocallis rupestris Extracts and Their Quality Evaluation by HPLC-DAD-MS3 Analysis
Next Article in Special Issue
Electronic Structure and Mesoscopic Simulations of Nonylphenol Ethoxylate Surfactants. A Combined DFT and DPD Study
Previous Article in Journal
Marrubiin
Previous Article in Special Issue
Ab Initio Calculations of Possible γ-Gauche Effects in the 13C-NMR for Methine and Carbonyl Carbons in Precise Polyethylene Acrylic Acid Copolymers
Molecules 2013, 18(8), 9061-9116; doi:10.3390/molecules18089061
Article

Determining Chemical Reactivity Driving Biological Activity from SMILES Transformations: The Bonding Mechanism of Anti-HIV Pyrimidines

*  and
Received: 30 May 2013; in revised form: 22 July 2013 / Accepted: 24 July 2013 / Published: 30 July 2013
(This article belongs to the Special Issue Computational Chemistry)
Download PDF [1641 KB, uploaded 18 June 2014]
Abstract: Assessing the molecular mechanism of a chemical-biological interaction and bonding stands as the ultimate goal of any modern quantitative structure-activity relationship (QSAR) study. To this end the present work employs the main chemical reactivity structural descriptors (electronegativity, chemical hardness, chemical power, electrophilicity) to unfold the variational QSAR though their min-max correspondence principles as applied to the Simplified Molecular Input Line Entry System (SMILES) transformation of selected uracil derivatives with anti-HIV potential with the aim of establishing the main stages whereby the given compounds may inhibit HIV infection. The bonding can be completely described by explicitly considering by means of basic indices and chemical reactivity principles two forms of SMILES structures of the pyrimidines, the Longest SMILES Molecular Chain (LoSMoC) and the Branching SMILES (BraS), respectively, as the effective forms involved in the anti-HIV activity mechanism and according to the present work, also necessary intermediates in molecular pathways targeting/docking biological sites of interest.
Keywords: anti-HIV activity; 1,3-disubstituted uracil derivatives; QSAR; SMILES; electronegativity; chemical hardness; chemical power; electrophilicity; chemical reactivity principles; lipophilicity anti-HIV activity; 1,3-disubstituted uracil derivatives; QSAR; SMILES; electronegativity; chemical hardness; chemical power; electrophilicity; chemical reactivity principles; lipophilicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Putz, M.V.; Dudaş, N.A. Determining Chemical Reactivity Driving Biological Activity from SMILES Transformations: The Bonding Mechanism of Anti-HIV Pyrimidines. Molecules 2013, 18, 9061-9116.

AMA Style

Putz MV, Dudaş NA. Determining Chemical Reactivity Driving Biological Activity from SMILES Transformations: The Bonding Mechanism of Anti-HIV Pyrimidines. Molecules. 2013; 18(8):9061-9116.

Chicago/Turabian Style

Putz, Mihai V.; Dudaş, Nicoleta A. 2013. "Determining Chemical Reactivity Driving Biological Activity from SMILES Transformations: The Bonding Mechanism of Anti-HIV Pyrimidines." Molecules 18, no. 8: 9061-9116.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert